Keros Therapeutics' stock has risen 2.5% since its last earnings report. Analysts are examining recent earnings estimates to gauge potential future performance.
- Keros Therapeutics reported earnings 30 days ago.
- The article examines earnings estimates for potential clues on the stock's future performance.
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.
Share this article